Skip to main content
Acta Crystallographica Section E: Crystallographic Communications logoLink to Acta Crystallographica Section E: Crystallographic Communications
. 2026 Jan 1;82(Pt 1):99–102. doi: 10.1107/S2056989025010874

The crystal structure of tetra­kis­(5-phenyl-1H-imidazole-κN3)zinc(II) dinitrate

Nomampondo Penelope Magwa a,*
Editor: S P Kelleyb
PMCID: PMC12810271  PMID: 41551555

In the title compound, the central zinc(II) ion coordinated by four 5-phenyl­imidazole ligands, with two nitrate anions providing charge balance·In the crystal, the nitrate ions occupy the voids formed by the [Zn(C9H8N2)4]2+ cations and function as counter-ions. The nitrate oxygen atoms participate in weak N—H⋯O hydrogen-bonding inter­actions.

Keywords: 5-phenyl-1H-imidazole, Zn-complex, crystal structure

Abstract

The title complex salt, [Zn(C9H8N2)4](NO3)2, features a central zinc(II) ion coordinated by four 5-phenyl­imidazole ligands, with two nitrate anions providing charge balance. It crystallizes in the monoclinic space group C2/c. In the crystal, the nitrate ions occupy the voids formed by the [Zn(C9H8N2)4]2+ cations and function as counter-ions. The nitrate oxygen atoms participate in strong N—H⋯O hydrogen-bonding inter­actions. The crystal studied was refined as a two-component twin.

1. Chemical context

The 5-phenyl-1H-imidazole scaffold is an important framework in medicinal chemistry due to its versatility and biological significance. It significantly contributes to the creation of pharmacologically active mol­ecules, particularly in the fields of HIV, anti­cancer, and anti­bacterial research (Abu Almaaty et al., 2021; Rashamuse et al., 2020, 2021; Roy et al., 2005). The imidazole moiety is frequently included in a variety of medicinal drugs, and its pharmacokinetic and pharmacodynamic qualities are further improved by the addition of a phenyl group at the 5-position (Devi et al., 2024; Blass et al., 2000). 5-Phenyl-1H-imidazole is a structurally straightforward aromatic heterocycle composed of a five-membered imidazole ring with two non-adjacent nitro­gen atoms substituted at the 5-position with a phenyl group. This basic structure has several functionalization sites, making it a promising starting point for drug discovery and synthetic modification. In addition to its biological value, imidazole derivatives, such as 5-phenyl-1H-imidazole, have shown great promise in coordination chemistry. These compounds readily form coordination complexes with a wide range of transition metals, including zinc, copper, ruthenium, and iron (Rashamuse et al., 2023; Baranoff et al., 2011; Magwa & Rashamuse, 2024; Bonomo et al., 1988; Carver et al., 2003; Li et al., 2024). In metal complexes, the nitro­gen atom in the imidazole ring works as a σ-donor ligand, typically binding through the sp2-hybridized nitro­gen atom (also known as the imine-type nitro­gen at position 3 of the ring). This coordination stabilizes the metal center compared to its unligated or aqua-ligated state, and significantly affects the complex’s redox potential, geometry, and chemical reactivity. These metal–imidazole complexes are important in bioinorganic chemistry because they frequently serve as models for metalloenzymes (Roy et al., 2005). Enzymes such as carbonic anhydrase and cytochrome c oxidase rely on imidazole moieties for catalytic activity and electron transport, respectively (Roy et al., 2005; Maneeta et al., 2024). Thus, synthesized imidazole–metal complexes offer important insights into enzyme functions and are being investigated for therapeutic uses including as imaging probes, anti­cancer medicines, and anti­bacterial compounds.1.

2. Structural commentary

The title compound crystallizes in the monoclinic space group C2/c, with the zinc(II) atom occupying a special position on a symmetry element. As a result, the molecule’s intrinsic symmetry matches the crystallographic symmetry, so only a fraction of the molecule is present in the asymmetric unit. The zinc(II) atom is coordinated by four 5-phenyl-1H-imidazole ligands, forming a distorted tetra­hedral geometry (Table 1, Fig. 1). This distortion is evident from the six N—Zn—N bond angles, which deviate slightly from the ideal tetra­hedral angle of 109.5°. The Zn—N bond lengths are consistent, with symmetry-equivalent values averaged to 1.986 Å, confirming a relatively symmetrical coordination sphere. The nitrate anions act as counter-ions and exhibit slight distortions from an ideal trigonal planar geometry (Table 1). These deviations arise from hydrogen-bonding inter­actions with the imidazole ligands, which are discussed in the Supra­molecular features section. Generally, the structural parameters and symmetry constraints define a stable, well-organized crystal structure, with the zinc center adopting a distorted tetra­hedral coordination environment stabilized by both covalent and non-covalent inter­actions. These interactions arise from crystal packing and intermolecular forces, which slightly adjust bond angles and distances to optimize crystal stability. As a result, the coordination sphere deviates from an ideal tetrahedron, reflecting the combined influence of both strong covalent bonding and secondary non-covalent forces.

Table 1. Selected geometric parameters (Å, °).

Zn1—N1 1.9882 (11) O2—N5 1.2295 (19)
Zn1—N3 1.9828 (11) O3—N5 1.2585 (18)
O1—N5 1.2606 (16)    
       
N1i—Zn1—N1 105.44 (6) O2—N5—O1 119.84 (14)
N3—Zn1—N1i 110.19 (4) O2—N5—O3 123.65 (14)
N3—Zn1—N1 111.70 (4) O3—N5—O1 116.51 (13)
N3—Zn1—N3i 107.68 (7)    

Symmetry code: (i) Inline graphic.

Figure 1.

Figure 1

Displacement ellipsoid plot of the title compound showing the atom-numbering scheme and the inter­actions between the nitrate ion and the 5-phenyl-1H-imidazole ligand (dashed lines). Displacement ellipsoids are drawn at the 50% probability level. Unlabelled atoms are generated by the symmetry operation −x + 1, y, −z + Inline graphic.

3. Supra­molecular features

The mol­ecular packing of the title compound is illustrated in Fig. 2, showing how the three-dimensional arrangement of [Zn(C9H8N2)4]2+ cations and nitrate anions defines the crystal structure. The nitrate ions play an active role in shaping the packing by accepting strong N—H⋯·O hydrogen bonds (Table 2) with hydrogen atoms from the imidazole moieties. Each nitrate anion accepts three hydrogen bonds from neighboring cations, while each cation inter­acts with two nitrate anions and several adjacent cations. In addition to hydrogen bonding, phenyl rings from adjacent cations exhibit notable π–π stacking and edge-to-face inter­actions, characterized by a parallel-displaced arrangement [centroid–centroid distance = 4.037 (2) Å, interplanar separation = 3.408 Å, slippage = 2.165 Å] and a T-shaped contact [centroid–centroid distance = 5.536 (2) Å, ring-normal angle = 69.9°, centroid-to-plane separations = 3.835 and 4.137 Å], highlighting non-covalent cation–cation contacts that contribute to the crystal cohesion. Together, these hydrogen bonds and aromatic inter­actions organize the crystal into a robust structure, integrating electrostatic forces, directional hydrogen bonding, and π–π stacking. to optimize the crystal stability.

Figure 2.

Figure 2

Packing diagram of the title compound showing the nitrate cations lying in the voids between the cationic complexes.

Table 2. Hydrogen-bond geometry (Å, °).

D—H⋯A D—H H⋯A DA D—H⋯A
N2—H2⋯O1 0.88 1.91 2.7425 (14) 156
N4—H4⋯O1ii 0.88 2.30 2.9779 (16) 134
N4—H4⋯O3ii 0.88 2.07 2.8326 (18) 145
C5—H5⋯O3iii 0.95 2.46 3.3915 (19) 166
C6—H6⋯O2iv 0.95 2.54 3.278 (2) 135

Symmetry codes: (ii) Inline graphic; (iii) Inline graphic; (iv) Inline graphic.

4. Database survey

The title complex, represents a new addition to the family of zinc(II)–imidazole derivatives, a group known for their structural flexibility and diverse coordination behavior. Zinc(II) readily adopts various geometries, while imidazole ligands provide multiple coordination possibilities. A search of the Cambridge Structural Database (CSD, Version 5.45, March 2024 update; Groom et al., 2016) and Google Scholar found no prior example of a complex with the same formulation, [Zn(C9H8N2)4]2+·2NO3, confirming its originality. Related zinc–imidazole complexes are rare but include Zn(C3H4N2)42+ (CCDC No. 639568; Huang et al., 2007), [Zn(dmit)4][BF4]2, and [Zn(dmit)4][NO3]2 (CCDC Nos. 772715 and 772716; William et al., 2010), helical frameworks [Zn(bdt)]2+ (CCDC Nos. 772872 and 772873; Liu et al., 2010), and Zn(C4H6N2)42+ (CDCC No. 861722; Reedijk et al., 2012). Structural comparison with these reported systems shows that Zn—N bond lengths in tetra­hedral ZnII complexes generally range from 1.97–2.00 Å, consistent with the mean value of 1.986 Å in the present compound. Likewise, the observed N—Zn—N bond angles [105.44 (6)–111.70 (4)°] fall within the expected range of 104–113° reported for similar complexes in the CSD, confirming a slightly distorted tetra­hedral environment. Such deviations from the ideal tetra­hedral angle of 109.5° are common and have been attributed to steric effects of bulky substituents and hydrogen-bonding inter­actions (Huang et al., 2007; William et al., 2010; Reedijk et al., 2012). In this complex, the distortion likely arises from the phenyl-imidazole ligands and nitrate-mediated hydrogen bonding, in agreement with established structural trends for imidazole-based ZnII systems.

5. Synthesis and crystallization

To prepare the title compound, 0.14 g (0.485 mmol) of zinc nitrate hexa­hydrate were added to a stirred solution of 0.58 g (4 mmol) of 4-phenyl­imidazole in a solvent mixture of di­chloro­methane (DCM, 25 mL) and methanol (MeOH, 3 mL) in a round-bottom flask. The resulting slurry was stirred continuously for 5 h until a clear solution formed, after which the solution was filtered, and the filtrate was allowed to evaporate slowly at ambient temperatures (298–300 K). After 16 days, light-yellow crystals formed, which were collected by filtration and dried in air. The synthesis is shown in the scheme below.5.

6. Refinement

Crystal data, data collection and structure refinement details are summarized in Table 3. All C-bound H were placed in geometrically idealized positions and refined using the riding model, with isotropic displacement parameters set to 1.2 or 1.5 times those of the corresponding parent carbon atoms. The crystal studied was refined as a two-component twin, and an appropriate twin law was applied during the refinement process. A B-level PLAT910 alert indicates that low-angle reflections below θmin = 3.92° were omitted. This exclusion is intentional because the reflections at such low angles were either partially obscured by the beamstop or detector gap or severely overloaded. The omission prevents systematic errors in intensity data without affecting the completeness of the dataset or the refinement stability.

Table 3. Experimental details.

Crystal data
Chemical formula [Zn(C9H8N2)4](NO3)2
M r 766.08
Crystal system, space group Monoclinic, C2/c
Temperature (K) 100
a, b, c (Å) 20.2757 (5), 8.5411 (2), 20.2328 (5)
β (°) 94.908 (1)
V3) 3491.00 (15)
Z 4
Radiation type Mo Kα
μ (mm−1) 0.77
Crystal size (mm) 0.33 × 0.28 × 0.21
 
Data collection
Diffractometer Bruker D8 Venture Photon CCD area detector
Absorption correction Multi-scan (SADABS; Krause et al., 2015)
Tmin, Tmax 0.676, 0.746
No. of measured, independent and observed [I > 2σ(I)] reflections 37634, 4362, 3778
R int 0.039
(sin θ/λ)max−1) 0.668
 
Refinement
R[F2 > 2σ(F2)], wR(F2), S 0.032, 0.083, 1.08
No. of reflections 4131
No. of parameters 240
H-atom treatment H-atom parameters constrained
Δρmax, Δρmin (e Å−3) 0.58, −0.54

Computer programs: APEX3 and SAINT (Bruker, 2016), OLEX2.solve (Bourhis et al., 2015), SHELXL2018/3 (Sheldrick, 2015) and OLEX2 (Dolomanov et al., 2009).

Supplementary Material

Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989025010874/ev2022sup1.cif

e-82-00099-sup1.cif (1.1MB, cif)

Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989025010874/ev2022Isup3.hkl

e-82-00099-Isup3.hkl (329.6KB, hkl)

CCDC reference: 2433548

Additional supporting information: crystallographic information; 3D view; checkCIF report

Additional supporting information: crystallographic information; 3D view; checkCIF report

supplementary crystallographic information

Tetrakis(5-phenyl-1H-imidazole-κN3)zinc(II) dinitrate . Crystal data

[Zn(C9H8N2)4](NO3)2 F(000) = 1584
Mr = 766.08 Dx = 1.458 Mg m3
Monoclinic, C2/c Mo Kα radiation, λ = 0.71073 Å
a = 20.2757 (5) Å Cell parameters from 9886 reflections
b = 8.5411 (2) Å θ = 3.9–28.3°
c = 20.2328 (5) Å µ = 0.77 mm1
β = 94.908 (1)° T = 100 K
V = 3491.00 (15) Å3 Block, colourless
Z = 4 0.33 × 0.28 × 0.21 mm

Tetrakis(5-phenyl-1H-imidazole-κN3)zinc(II) dinitrate . Data collection

Bruker D8 Venture Photon CCD area detector diffractometer 3778 reflections with I > 2σ(I)
Graphite monochromator Rint = 0.039
ω scans θmax = 28.3°, θmin = 3.9°
Absorption correction: multi-scan (SADABS; Krause et al., 2015) h = −26→26
Tmin = 0.676, Tmax = 0.746 k = −11→11
37634 measured reflections l = −26→26
4362 independent reflections

Tetrakis(5-phenyl-1H-imidazole-κN3)zinc(II) dinitrate . Refinement

Refinement on F2 Primary atom site location: iterative
Least-squares matrix: full Hydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.032 H-atom parameters constrained
wR(F2) = 0.083 w = 1/[σ2(Fo2) + (0.0364P)2 + 3.5607P] where P = (Fo2 + 2Fc2)/3
S = 1.08 (Δ/σ)max < 0.001
4131 reflections Δρmax = 0.58 e Å3
240 parameters Δρmin = −0.54 e Å3
0 restraints

Tetrakis(5-phenyl-1H-imidazole-κN3)zinc(II) dinitrate . Special details

Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.

Tetrakis(5-phenyl-1H-imidazole-κN3)zinc(II) dinitrate . Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)

x y z Uiso*/Ueq
Zn1 0.500000 0.49768 (2) 0.250000 0.01768 (9)
N1 0.53202 (5) 0.63867 (13) 0.32410 (5) 0.0197 (2)
N2 0.59820 (5) 0.73921 (13) 0.40463 (5) 0.0200 (2)
H2 0.631233 0.748065 0.435560 0.024*
N3 0.42707 (6) 0.36069 (13) 0.27471 (5) 0.0200 (2)
N4 0.34930 (6) 0.27794 (14) 0.33445 (6) 0.0259 (3)
H4 0.319267 0.278378 0.363381 0.031*
C1 0.58505 (7) 0.61404 (16) 0.36617 (6) 0.0207 (3)
H1 0.610201 0.520057 0.368544 0.025*
C2 0.51038 (6) 0.78840 (15) 0.33734 (6) 0.0193 (2)
H2A 0.473079 0.838709 0.315000 0.023*
C3 0.55109 (6) 0.85247 (15) 0.38757 (6) 0.0180 (2)
C4 0.55155 (7) 1.00688 (14) 0.41913 (6) 0.0181 (2)
C5 0.61083 (7) 1.07279 (17) 0.44644 (7) 0.0243 (3)
H5 0.651257 1.017424 0.444524 0.029*
C6 0.61072 (8) 1.21885 (17) 0.47632 (8) 0.0295 (3)
H6 0.651080 1.262996 0.495073 0.035*
C7 0.55174 (8) 1.30109 (17) 0.47897 (8) 0.0291 (3)
H7 0.551861 1.401404 0.499269 0.035*
C8 0.49274 (7) 1.23615 (17) 0.45189 (7) 0.0255 (3)
H8 0.452460 1.292215 0.453632 0.031*
C9 0.49242 (6) 1.08976 (16) 0.42230 (6) 0.0211 (3)
H9 0.451869 1.045539 0.404097 0.025*
C10 0.38769 (7) 0.39837 (16) 0.32101 (7) 0.0243 (3)
H10 0.386876 0.497897 0.341889 0.029*
C11 0.41252 (6) 0.20659 (15) 0.25808 (6) 0.0198 (2)
H11 0.432820 0.147352 0.225633 0.024*
C12 0.36429 (6) 0.15292 (15) 0.29572 (6) 0.0190 (2)
C13 0.33328 (6) −0.00064 (14) 0.30077 (7) 0.0186 (3)
C14 0.33421 (6) −0.10875 (16) 0.24892 (7) 0.0218 (3)
H14 0.354879 −0.082393 0.210011 0.026*
C15 0.30492 (7) −0.25450 (17) 0.25434 (7) 0.0252 (3)
H15 0.305487 −0.327515 0.218969 0.030*
C16 0.27481 (7) −0.29434 (17) 0.31107 (7) 0.0262 (3)
H16 0.255042 −0.394519 0.314562 0.031*
C17 0.27360 (7) −0.18784 (18) 0.36261 (7) 0.0276 (3)
H17 0.252828 −0.215062 0.401350 0.033*
C18 0.30266 (7) −0.04139 (18) 0.35785 (7) 0.0242 (3)
H18 0.301760 0.031187 0.393345 0.029*
O1 0.67549 (5) 0.73031 (12) 0.52263 (5) 0.0244 (2)
O2 0.71165 (7) 0.51909 (14) 0.48003 (8) 0.0457 (4)
O3 0.74061 (6) 0.5820 (2) 0.58356 (6) 0.0526 (4)
N5 0.70964 (6) 0.60692 (15) 0.52796 (6) 0.0258 (3)

Tetrakis(5-phenyl-1H-imidazole-κN3)zinc(II) dinitrate . Atomic displacement parameters (Å2)

U11 U22 U33 U12 U13 U23
Zn1 0.01953 (12) 0.01818 (12) 0.01528 (12) 0.000 0.00119 (8) 0.000
N1 0.0211 (5) 0.0212 (5) 0.0165 (5) 0.0007 (4) 0.0007 (4) −0.0006 (4)
N2 0.0191 (5) 0.0229 (5) 0.0175 (5) 0.0024 (4) −0.0015 (4) −0.0007 (4)
N3 0.0213 (5) 0.0199 (5) 0.0190 (5) 0.0001 (4) 0.0016 (4) 0.0005 (4)
N4 0.0234 (6) 0.0241 (6) 0.0320 (6) −0.0023 (4) 0.0123 (5) −0.0067 (5)
C1 0.0220 (6) 0.0218 (6) 0.0182 (6) 0.0025 (5) 0.0013 (5) 0.0002 (5)
C2 0.0190 (6) 0.0220 (6) 0.0169 (6) 0.0023 (5) 0.0009 (4) 0.0007 (5)
C3 0.0172 (5) 0.0218 (6) 0.0153 (5) 0.0011 (5) 0.0028 (4) 0.0014 (5)
C4 0.0198 (6) 0.0205 (6) 0.0141 (5) 0.0000 (4) 0.0024 (4) 0.0016 (4)
C5 0.0200 (6) 0.0241 (7) 0.0287 (7) −0.0002 (5) 0.0021 (5) −0.0006 (5)
C6 0.0274 (7) 0.0246 (7) 0.0359 (8) −0.0054 (6) −0.0001 (6) −0.0027 (6)
C7 0.0381 (8) 0.0195 (6) 0.0300 (7) 0.0001 (6) 0.0039 (6) −0.0025 (5)
C8 0.0281 (7) 0.0257 (7) 0.0233 (6) 0.0072 (5) 0.0051 (5) 0.0017 (5)
C9 0.0200 (6) 0.0265 (7) 0.0169 (6) 0.0017 (5) 0.0012 (4) 0.0012 (5)
C10 0.0232 (6) 0.0202 (6) 0.0302 (7) −0.0007 (5) 0.0062 (5) −0.0043 (5)
C11 0.0207 (6) 0.0207 (6) 0.0181 (6) −0.0005 (5) 0.0020 (5) −0.0018 (5)
C12 0.0171 (5) 0.0206 (6) 0.0190 (6) 0.0014 (5) 0.0000 (4) −0.0020 (5)
C13 0.0153 (6) 0.0199 (6) 0.0201 (6) 0.0004 (4) −0.0004 (5) 0.0006 (5)
C14 0.0187 (6) 0.0237 (6) 0.0231 (6) 0.0024 (5) 0.0024 (5) −0.0015 (5)
C15 0.0236 (6) 0.0226 (6) 0.0287 (7) 0.0006 (5) −0.0009 (5) −0.0059 (5)
C16 0.0253 (7) 0.0212 (6) 0.0311 (7) −0.0039 (5) −0.0038 (5) 0.0023 (6)
C17 0.0287 (7) 0.0310 (7) 0.0230 (7) −0.0067 (6) 0.0013 (5) 0.0033 (6)
C18 0.0256 (7) 0.0267 (7) 0.0203 (6) −0.0042 (5) 0.0022 (5) −0.0021 (5)
O1 0.0228 (5) 0.0292 (5) 0.0207 (5) 0.0060 (4) −0.0011 (4) −0.0020 (4)
O2 0.0471 (8) 0.0277 (6) 0.0664 (9) −0.0079 (5) 0.0281 (7) −0.0178 (6)
O3 0.0389 (7) 0.0844 (11) 0.0365 (7) 0.0302 (7) 0.0154 (5) 0.0324 (7)
N5 0.0219 (5) 0.0271 (6) 0.0299 (6) 0.0007 (5) 0.0111 (5) 0.0059 (5)

Tetrakis(5-phenyl-1H-imidazole-κN3)zinc(II) dinitrate . Geometric parameters (Å, º)

Zn1—N1i 1.9881 (11) C7—H7 0.9500
Zn1—N1 1.9882 (11) C7—C8 1.388 (2)
Zn1—N3i 1.9829 (11) C8—H8 0.9500
Zn1—N3 1.9828 (11) C8—C9 1.386 (2)
N1—C1 1.3297 (17) C9—H9 0.9500
N1—C2 1.3856 (17) C10—H10 0.9500
N2—H2 0.8800 C11—H11 0.9500
N2—C1 1.3357 (17) C11—C12 1.3689 (18)
N2—C3 1.3824 (16) C12—C13 1.4618 (17)
N3—C10 1.3217 (18) C13—C14 1.3990 (19)
N3—C11 1.3841 (17) C13—C18 1.4012 (19)
N4—H4 0.8800 C14—H14 0.9500
N4—C10 1.3320 (18) C14—C15 1.388 (2)
N4—C12 1.3739 (17) C15—H15 0.9500
C1—H1 0.9500 C15—C16 1.388 (2)
C2—H2A 0.9500 C16—H16 0.9500
C2—C3 1.3675 (18) C16—C17 1.386 (2)
C3—C4 1.4649 (18) C17—H17 0.9500
C4—C5 1.3975 (19) C17—C18 1.389 (2)
C4—C9 1.3985 (18) C18—H18 0.9500
C5—H5 0.9500 O1—N5 1.2606 (16)
C5—C6 1.386 (2) O2—N5 1.2295 (19)
C6—H6 0.9500 O3—N5 1.2585 (18)
C6—C7 1.392 (2)
N1i—Zn1—N1 105.44 (6) C8—C7—H7 120.1
N3—Zn1—N1i 110.19 (4) C7—C8—H8 119.9
N3—Zn1—N1 111.70 (4) C9—C8—C7 120.20 (13)
N3i—Zn1—N1 110.18 (4) C9—C8—H8 119.9
N3i—Zn1—N1i 111.70 (4) C4—C9—H9 119.9
N3—Zn1—N3i 107.68 (7) C8—C9—C4 120.27 (13)
C1—N1—Zn1 125.51 (9) C8—C9—H9 119.9
C1—N1—C2 105.92 (11) N3—C10—N4 110.84 (12)
C2—N1—Zn1 128.06 (9) N3—C10—H10 124.6
C1—N2—H2 125.8 N4—C10—H10 124.6
C1—N2—C3 108.39 (11) N3—C11—H11 125.3
C3—N2—H2 125.8 C12—C11—N3 109.31 (11)
C10—N3—Zn1 122.94 (9) C12—C11—H11 125.3
C10—N3—C11 105.94 (11) N4—C12—C13 122.68 (12)
C11—N3—Zn1 130.38 (9) C11—C12—N4 105.10 (11)
C10—N4—H4 125.6 C11—C12—C13 132.17 (12)
C10—N4—C12 108.79 (11) C14—C13—C12 120.42 (12)
C12—N4—H4 125.6 C14—C13—C18 119.31 (12)
N1—C1—N2 110.88 (12) C18—C13—C12 120.27 (12)
N1—C1—H1 124.6 C13—C14—H14 120.0
N2—C1—H1 124.6 C15—C14—C13 119.98 (12)
N1—C2—H2A 125.3 C15—C14—H14 120.0
C3—C2—N1 109.40 (11) C14—C15—H15 119.8
C3—C2—H2A 125.3 C14—C15—C16 120.45 (13)
N2—C3—C4 122.87 (11) C16—C15—H15 119.8
C2—C3—N2 105.41 (11) C15—C16—H16 120.0
C2—C3—C4 131.70 (12) C17—C16—C15 119.92 (13)
C5—C4—C3 120.55 (12) C17—C16—H16 120.0
C5—C4—C9 119.31 (12) C16—C17—H17 119.9
C9—C4—C3 120.14 (12) C16—C17—C18 120.27 (13)
C4—C5—H5 119.9 C18—C17—H17 119.9
C6—C5—C4 120.10 (13) C13—C18—H18 120.0
C6—C5—H5 119.9 C17—C18—C13 120.07 (13)
C5—C6—H6 119.9 C17—C18—H18 120.0
C5—C6—C7 120.28 (14) O2—N5—O1 119.84 (14)
C7—C6—H6 119.9 O2—N5—O3 123.65 (14)
C6—C7—H7 120.1 O3—N5—O1 116.51 (13)
C8—C7—C6 119.83 (13)
Zn1—N1—C1—N2 171.98 (9) C4—C5—C6—C7 −0.4 (2)
Zn1—N1—C2—C3 −172.01 (9) C5—C4—C9—C8 0.38 (19)
Zn1—N3—C10—N4 −171.23 (9) C5—C6—C7—C8 0.3 (2)
Zn1—N3—C11—C12 169.66 (9) C6—C7—C8—C9 0.1 (2)
N1—C2—C3—N2 0.22 (14) C7—C8—C9—C4 −0.4 (2)
N1—C2—C3—C4 178.14 (12) C9—C4—C5—C6 0.0 (2)
N2—C3—C4—C5 26.89 (19) C10—N3—C11—C12 −0.57 (15)
N2—C3—C4—C9 −152.98 (12) C10—N4—C12—C11 −1.02 (16)
N3—C11—C12—N4 0.97 (15) C10—N4—C12—C13 176.80 (12)
N3—C11—C12—C13 −176.56 (13) C11—N3—C10—N4 −0.09 (16)
N4—C12—C13—C14 160.74 (13) C11—C12—C13—C14 −22.1 (2)
N4—C12—C13—C18 −19.7 (2) C11—C12—C13—C18 157.50 (15)
C1—N1—C2—C3 0.08 (14) C12—N4—C10—N3 0.71 (17)
C1—N2—C3—C2 −0.44 (14) C12—C13—C14—C15 179.68 (12)
C1—N2—C3—C4 −178.59 (12) C12—C13—C18—C17 −179.60 (13)
C2—N1—C1—N2 −0.37 (15) C13—C14—C15—C16 −0.2 (2)
C2—C3—C4—C5 −150.72 (14) C14—C13—C18—C17 0.0 (2)
C2—C3—C4—C9 29.4 (2) C14—C15—C16—C17 0.3 (2)
C3—N2—C1—N1 0.52 (15) C15—C16—C17—C18 −0.2 (2)
C3—C4—C5—C6 −179.86 (13) C16—C17—C18—C13 0.1 (2)
C3—C4—C9—C8 −179.74 (12) C18—C13—C14—C15 0.1 (2)

Symmetry code: (i) −x+1, y, −z+1/2.

Tetrakis(5-phenyl-1H-imidazole-κN3)zinc(II) dinitrate . Hydrogen-bond geometry (Å, º)

D—H···A D—H H···A D···A D—H···A
N2—H2···O1 0.88 1.91 2.7425 (14) 156
N4—H4···O1ii 0.88 2.30 2.9779 (16) 134
N4—H4···O3ii 0.88 2.07 2.8326 (18) 145
C5—H5···O3iii 0.95 2.46 3.3915 (19) 166
C6—H6···O2iv 0.95 2.54 3.278 (2) 135

Symmetry codes: (ii) −x+1, −y+1, −z+1; (iii) −x+3/2, −y+3/2, −z+1; (iv) x, y+1, z.

Funding Statement

The author gratefully acknowledges the financial support provided by the College of Science, Engineering and Technology at the University of South Africa (UNISA), as well as the National Research Foundation (NRF) of South Africa through the Thuthuka funding programme (grant No. UID: 129744).

References

  1. Abu Almaaty, A. H., Toson, E. E. M., El-Sayed, E. H., Tantawy, M. A. M., Fayad, E., Abu Ali, O. A. & Zaki, I. (2021). Molecules26, 1706. [DOI] [PMC free article] [PubMed]
  2. Baranoff, E., Fantacci, S., De Angelis, F., Zhang, X., Scopelliti, R., Grätzel, M. & Nazeeruddin, Md. K. (2011). Inorg. Chem.50, 451–462. [DOI] [PubMed]
  3. Blass, B. E., Huang, C. T., Kawamoto, R. M., Li, M., Liu, S., Portlock, D. E., Rennells, W. M. & Simmons, M. (2000). Bioorg. Med. Chem. Lett.10, 1543–1545. [DOI] [PubMed]
  4. Bonomo, R. P., Riggi, F. & Di Bilio, A. J. (1988). Inorg. Chem.27, 2510–2512.
  5. Bourhis, L. J., Dolomanov, O. V., Gildea, R. J., Howard, J. A. K. & Puschmann, H. (2015). Acta Cryst. A71, 59–75. [DOI] [PMC free article] [PubMed]
  6. Bruker (2016). APEX3 and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.
  7. Carver, G., Tregenna-Piggott, P. L. W., Barra, A.-L., Neels, A. & Stride, J. A. (2003). Inorg. Chem.42, 5771–5777. [DOI] [PubMed]
  8. Devi, M. M., Devi, K. S., Singh, O. M. & Singh, T. P. (2024). Heterocycl. Commun.30, 20220173.
  9. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K. & Puschmann, H. (2009). J. Appl. Cryst.42, 339–341.
  10. Groom, C. R., Bruno, I. J., Lightfoot, M. P. & Ward, S. C. (2016). Acta Cryst. B72, 171–179. [DOI] [PMC free article] [PubMed]
  11. Huang, F., Song, W.-D. & Li, S.-D. (2007). Acta Cryst. E63, m388–m389.
  12. Krause, L., Herbst-Irmer, R., Sheldrick, G. M. & Stalke, D. (2015). J. Appl. Cryst.48, 3–10. [DOI] [PMC free article] [PubMed]
  13. Li, Z., Bhowmik, S., Sagresti, L., Brancato, G., Smith, M., Benson, D. E., Li, P. & Merz, K. M. Jr (2024). J. Chem. Theory Comput.20, 15, 6706–6716. [DOI] [PMC free article] [PubMed]
  14. Liu, W.-T., Qu, Y.-C., Lin, Z.-J. & Tong, M.-L. (2010). CrystEng­Comm12, 3487–3489.
  15. Magwa, N. P. & Rashamuse, T. J. (2024). Acta Cryst. E80, 1054–1058. [DOI] [PMC free article] [PubMed]
  16. Rashamuse, T. J., Coyanis, E. M., Erasmus, R. & Magwa, N. P. (2023). Int. J. Mol. Sci.24, 12260. [DOI] [PMC free article] [PubMed]
  17. Rashamuse, T. J., Fish, M. Q., Coyanis, E. M. & Bode, M. L. (2021). Molecules26, 6203. [DOI] [PMC free article] [PubMed]
  18. Rashamuse, T. J., Njengele, Z., Coyanis, E. M., Sayed, Y., Mosebi, S. & Bode, M. L. (2020). Eur. J. Med. Chem.190, 112111. [DOI] [PubMed]
  19. Reedijk, J., Albada, G. A. van, Limburg, B., Mutikainen, I. & Turpeinen, U. (2012). Acta Cryst. E68, m90. [DOI] [PMC free article] [PubMed]
  20. Roy, K. & Leonard, T. J. (2005). Bioorg. Med. Chem.13, 2967–2973. [DOI] [PubMed]
  21. Sheldrick, G. M. (2015). Acta Cryst. C71, 3–8.
  22. Williams, D. J., Arrowood, K. A., Bloodworth, L. M., Carmack, A. L., Gulla, D., Gray, M. W., Maasen, I., Rizvi, F., Rosenbaum, S. L., Gwaltney, K. P. & VanDerveer, D. (2010). J. Chem. Crystallogr.40, 1074–1077.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989025010874/ev2022sup1.cif

e-82-00099-sup1.cif (1.1MB, cif)

Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989025010874/ev2022Isup3.hkl

e-82-00099-Isup3.hkl (329.6KB, hkl)

CCDC reference: 2433548

Additional supporting information: crystallographic information; 3D view; checkCIF report

Additional supporting information: crystallographic information; 3D view; checkCIF report


Articles from Acta Crystallographica Section E: Crystallographic Communications are provided here courtesy of International Union of Crystallography

RESOURCES